Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Ross River Virus Vaccine Follow-up
NCT01604746Phase 3Completed
- Sponsor
- Resilience Government Services
- Start
- Jul 2012
- Primary completion
- Apr 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of inactivated Ross River virus vaccine in Ross River virus infection, sponsored by Resilience Government Services. Started Jul 2012; status: completed.
02
Drugs
inactivated Ross River virus vaccine
03
Conditions
Ross River virus infection
Beyond the preview
Go deeper on NCT01604746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01604746.